Johnson & Johnson’s Nanobiotix NBTX Stock Holding History

Johnson & Johnson’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$175M	Hold	5,623,816	–	–	23.01%	2
2026 Q2	$212M	Hold	5,623,816	–	–	26.55%	2
2026 Q1	$174M	Hold	5,623,816	–	–	26.61%	2
2025 Q4	$130M	Hold	5,623,816	–	–	23.43%	2
2025 Q3	$106M	Hold	5,623,816	–	–	21.08%	2
2025 Q2	$25.5M	Hold	5,623,816	–	–	7.62%	5
2025 Q1	$20.1M	Hold	5,623,816	–	–	5.89%	7
2024 Q4	$16.1M	Hold	5,623,816	–	–	4.18%	10
2024 Q3	$32.3M	Hold	5,623,816	–	–	7.57%	6
2024 Q2	$28.1M	Hold	5,623,816	–	–	7.02%	6
2024 Q1	$36.6M	Hold	5,623,816	–	–	0.83%	8
2023 Q4	$40.9M	Buy	5,623,816 +4,664,179	+486%	+$29.6M	0.93%	6
2023 Q3	$8.4M	Buy	+959,637	New	+$7.96M	3.09%	9

Other funds holding NBTX

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Johnson & Johnson's NBTX Position: Q3 2026 in Review

Johnson & Johnson held its Nanobiotix (NBTX) position steady in Q3 2026 at 5,623,816 shares worth $175M. The position accounts for 23.01% of the portfolio, ranked #2.

Johnson & Johnson first reported a position in NBTX in Q3 2023 and has held it in 13 quarters since. The position peaked at $212M in Q2 2026. 10 funds tracked by Wall St. Rank hold NBTX as of Q3 2026.

Johnson & Johnson held 5,623,816 shares of Nanobiotix worth $175M as of Q3 2026.
Johnson & Johnson left its Nanobiotix share count unchanged in Q3 2026.
Nanobiotix made up 23.01% of Johnson & Johnson's portfolio in Q3 2026, its #2 holding.
Johnson & Johnson first reported a position in Nanobiotix in Q3 2023 and has held it in 13 quarters since.
Johnson & Johnson's Nanobiotix position peaked at $212M in Q2 2026.
10 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2026.

Based on Johnson & Johnson's 13F filing for Q3 2026, filed 26 Oct 2026.